Ambu Forever ForwardShare informationAnnual key figuresQuarterly resultsOwnershipShare CapitalDividend PolicyAnalystsConsensus estimates searchmenu Ambu Forever ForwardclosesearchEndoscopykeyboard_arrow_downcloseSINGLE-USE ENDOSCOPYPulmonologyBronchoscopesDisplaying UnitsProductsOfstead webinaraScope 4 Broncho Guys studyProceduresIntubationOne Lung VentilationSecretion ManagementBAL & BWBedside PDTTrainingTopicsaScope 5 Broncho benefitsBronchoscope availabilityInfection ControlHealth EconomicsEnvironmental ImpactClinical EvidenceAmbu® aScope™EAR, NOSE, THROAT (ENT)RhinolaryngoscopesDisplaying UnitsProductsProceduresFlexible laryngoscopyIn-office biopsySwallowing assessmentsTopics7 ways for single-useSingle-use rhinolaryngoscope comparisonSimplify bedside swallowing assessmentsClinical EvidenceGastroenterologyDuodenoscopeGastroscopeDisplaying UnitsProductsTopicsInfection ControlaScope Duodeno benefitsUrologyCystoscopeDisplaying UnitsProductsTopicsaScope 4 Cysto benefitsCost-comparison in urologyNeurologykeyboard_arrow_downclosePatient monitoring and diagnosticsNeurologyEEG ElectrodesEMG ElectrodesEMG Guided InjectionsIntraoperative MonitoringProductsStop cross contaminationClinical EvidenceAmbu® Neuroline EEG CupAmbu® Neuroline EMG NeedlesAmbu® Neuroline Surface ElectrodesCardiologykeyboard_arrow_downclosePatient monitoring and diagnosticsCardiologyECG ElectrodesProductsClinical EvidenceAmbu® BlueSensor ECG ElectrodesAmbu® WhiteSensor ECG ElectrodesAirway Management & Anaesthesiakeyboard_arrow_downcloseAirway Management and AnaesthesiaBronchoscopesVideo LaryngoscopesDouble Lumen TubesSingle Lumen TubesEndobronchial BlockersLaryngeal MasksFace MasksBreathing BagsResuscitatorsProductsVivaSight-DL Cost EffectivenessDownload summaryClinical EvidenceAmbu® AuraGain™Ambu® Aura-i™Ambu® AuraOnce™Ambu® AuraFlex™Ambu® Aura40™King Vision® Video LaryngoscopeAmbu® VivaSight™ 2 DLTVivaSight-SLAmbu® Face MasksEmergency Care & Trainingkeyboard_arrow_downcloseEmergency Care and TrainingResuscitatorsExtrication CollarsVideo LaryngoscopesALS Training ManikinsBLS Training ManikinsProductsTopicsOur iconic Ambu bagClinical EvidenceAmbu® ResuscitatorsAmbu® Military Mark lllAmbu® SPUR® IIAmbu® PEEP ValvesAmbu® ManikinssearchAmbu Forever ForwardCOVID-19InvestorsCareerMediaAboutkeyboard_arrow_downOur CompanyOur historyOur strategyManagementSustainabilityNewsContactkeyboard_arrow_downAmbu AddressesLocal DistributorsContact uspublicAmbu GlobalCorporate WebsiteEuropeAmericas and Asia Pacific InvestorsNewskeyboard_arrow_downNews from AmbuSign upReportskeyboard_arrow_downReports in EnglishReports in DanishPresentationskeyboard_arrow_downInvestor presentationsRecent webcastsCapital Markets DaysCalendarShare Infokeyboard_arrow_downShare informationAnnual key figuresQuarterly resultsOwnershipShare CapitalDividend PolicyAnalystsConsensus estimatesGovernancekeyboard_arrow_downCorporate GovernanceAnnual General MeetingInvestor Relations PolicyArticles of AssociationTwo share classesManagementBoard of DirectorsInvestor Relations Contact
InvestorsNewskeyboard_arrow_downNews from AmbuSign upReportskeyboard_arrow_downReports in EnglishReports in DanishPresentationskeyboard_arrow_downInvestor presentationsRecent webcastsCapital Markets DaysCalendarShare Infokeyboard_arrow_downShare informationAnnual key figuresQuarterly resultsOwnershipShare CapitalDividend PolicyAnalystsConsensus estimatesGovernancekeyboard_arrow_downCorporate GovernanceAnnual General MeetingInvestor Relations PolicyArticles of AssociationTwo share classesManagementBoard of DirectorsInvestor Relations ContactQuarterly resultsDownload to Excel: Quarterly results Q2 2022/23For definitions of key figures and ratios please refer to the notes in the consolidated financial statements.
